re: looking good for 2006 Launch of scilin (insulin) product is due this month in Philippines. Soon after that, in Thailand. Pol
09:11, Monday, 14 November 2005
Sydney - Monday - November 14: (RWE Australian Business News) -
SciGen Ltd (ASX code: SIE) has received a licence to market its insulin
product SciLin in the Kingdom of Thailand.
According to the World Health Organisation, more than 3.5
Million Thais are diagnosed with diabetes and a large number of the
population remains undiagnosed.
The insulin pharmaceutical market in Thailand is estimated to be
$US15 million.
This market is presently shared by two multinational companies.
Preparations are under way for the launch of SciLin in Thailand
early next year.
SciLin is currently registered and sold by SciGen or its
partners in India, Vietnam and Pakistan, and will soon be launched in
the Philippines.
Shares in SciGen fell 0.1c to 7.2c on Friday.
ENDS
- Forums
- ASX - By Stock
- new substantial holder
re: looking good for 2006 Launch of scilin (insulin) product is...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SIE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online